Letters
Breast screening
Will ductal carcinoma in situ defeat breast cancer screening?
BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b957 (Published 09 March 2009) Cite this as: BMJ 2009;338:b957
- John R Benson, consultant breast surgeon1
- 1Addenbrooke’s Hospital, Cambridge CB2 0QQ
- john.benson{at}addenbrookes.nhs.uk
Gøtzsche and colleagues focus on the inadequacy of patient information leaflets in the NHS breast screening programme.1
The failure to disclose information on ductal carcinoma in situ has aptly been described by a patient representative as a “closely guarded state secret.” Ductal carcinoma in situ constitutes up to a fifth of …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.